Zobrazeno 1 - 10
of 233
pro vyhledávání: '"E.S. Newlands"'
Autor:
L R Hiorns, F. J. Paradinas, S.Y Sharp, E.S Newlands, L.A Skelton, Brian Leyland-Jones, L.R Kelland, G Brunstrom, M.J Seckl
Publikováno v:
Journal of Inorganic Biochemistry. 77:95-104
The technique of comparative genomic hybridisation (CGH) has until recently been used to screen for common genomic abnormalities in fresh tumour material; it has identified previously unrecognised regions of amplification associated with poor prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d27d21abd96b3997b291061a9cfb43f
https://doi.org/10.1016/s0162-0134(99)00140-3
https://doi.org/10.1016/s0162-0134(99)00140-3
Autor:
E.S. Newlands
Publikováno v:
Current Obstetrics & Gynaecology. 5:19-24
Over the last 35 years the management of gestational trophoblastic disease (GTD) has been one of the success stories of clinical oncology. With proper follow-up and management, it should now be rare for any woman to die from a tumour deriving from GT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bee7c85261f7b74ac8a6c646abbb60ea
https://doi.org/10.1016/s0957-5847(05)80037-x
https://doi.org/10.1016/s0957-5847(05)80037-x
Autor:
D. Short, G.J.S. Rustin, L. Holden, R.H.J. Begent, K.D. Bagshawe, Mark Bower, C. Brock, E.S. Newlands
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 60
Between 1979 and 1995 we have treated 272 consecutive women with high-risk (GTT including 121 previously treated patients who were treated with the weekly EMA/CO (etoposide, methotrexate, actinomycin D alternating with cyclophosphamide and vincristin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcaa0fe75ea302db7dcc85255ec40df7
https://pubmed.ncbi.nlm.nih.gov/9833617
https://pubmed.ncbi.nlm.nih.gov/9833617
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 6(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73409d463e5239b91bb10cf7a1a48720
https://pubmed.ncbi.nlm.nih.gov/7669714
https://pubmed.ncbi.nlm.nih.gov/7669714
Autor:
E.S. Newlands
Publikováno v:
Clinical Oncology. 6:139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4577f9b4de8d420c9774d6efed354def
https://doi.org/10.1016/s0936-6555(05)80121-9
https://doi.org/10.1016/s0936-6555(05)80121-9
Publikováno v:
European Journal of Cancer and Clinical Oncology. 22:1479-1482
The effect of etoposide containing drug combinations on reproductive performance was studied in women successfully treated for gestational trophoblastic disease between 1977 and 1984. Of the 74 women who wished to get pregnant 57 (77.0%) succeeded in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e883c3748d5309d69c9b8de5a6d0b20d
https://doi.org/10.1016/0277-5379(86)90083-0
https://doi.org/10.1016/0277-5379(86)90083-0
Publikováno v:
International journal of nuclear medicine and biology. 5(2-3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f98ef984debc496b8777d469371b8d8
https://pubmed.ncbi.nlm.nih.gov/222703
https://pubmed.ncbi.nlm.nih.gov/222703
Publikováno v:
The Lancet. 308:744-745
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc5b29328a9bbb93ac668f0069aa9da
https://doi.org/10.1016/s0140-6736(76)90044-1
https://doi.org/10.1016/s0140-6736(76)90044-1
Publikováno v:
The Lancet. 331:412
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c22b0afefaf876a3794730d1740a346a
https://doi.org/10.1016/s0140-6736(88)91201-9
https://doi.org/10.1016/s0140-6736(88)91201-9
Autor:
K.D. Bagshawe, E.S. Newlands
Publikováno v:
The Lancet. 310:87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eed25b05652100ce72eca01076066304
https://doi.org/10.1016/s0140-6736(77)90088-5
https://doi.org/10.1016/s0140-6736(77)90088-5